• Led the successful development of a consumer oriented drug facts label through step-wise iterations, effectively balancing FDA feedback, medical and safety concerns with consumer behavior insights obtaining results that met or exceeded label comprehension / self-selection study performance threshold. • Created strategic guidance on global brand development, drawing key consumer insights, target profiles, commercial imperatives, brand guardrails and visuals. • Developed global tablet and packaging (primary & secondary) presentations. • Modeled business case and P&L analyses to support a number of launch scenarios.• Led the development of a global consumer education strategy and creative output collaborating with the local markets to identify relevant consumer, shopper, HCP and retail insights.• Led global creative agency selection process

• Recognized with global Commercial Excellence Award for successfully relaunching Children’s Advil to targeted pediatric HCPs in a compressed timeframe to support the growth of Children’s Advil to its leadership position• Trained and deployed 80 contract sales representatives • Launched first Advil website portal dedicated to HCPs with aggressive, clicinally-supported claims, a comprehensive bibliography of medical publications on ibuprofen, and downloadable patient/consumer education material• Leveraged with retail channels to enhance pharmacy programs and drive recommendation of PCH brands• Led development HCP targeting model that segments high potential targets and optimizes sample and promotional distribution• Strong experience in managing creative agencies and collaborating with Medical/Clinical affairs colleagues to engage with KOLs

• Effectively targeted MCO and PBM members/patients, using relevant ICD-9 and CPT diagnostic codes, to increase consumption of several key OTC products (Centrum Cardio, Caltrate, Advil, Alavert) that are either substitutes or complements to Rx products (Rx Statins, Rx Osteoporosis, Rx NSAID, Rx Allergy)• Led the creation, training and deployment of an ROI model and program scorecard to drive the optimization of Payer budget and priorities• Partnered with Rx division to identify mutual business opportunities for OTC and Rx marketing programs to key Payers

• Marketing Manager supporting Medical Sales Force of 420 people targeting Primary Care Physicians, Pediatricians, Ob/Gyns and Allergists driving marketing plans that succeeded in either obtaining or maintaining #1 professionally recommended claims for Caltrate (Ob/Gyns), Robitussin (PCPs), Alavert (Allergists) and Dimetapp (Pediatricians)• Successfully launched Rx to OTC switch, Alavert, to HCPs and doubled Alavert recommendations within one year. Overtook prior market leader, Claritin, and achieved #1 Allergist OTC NSA recommendation status and maintained status for two years• Successfully challenged status quo to secure regulatory approval for Caltrate claims supporting complementary use with Rx osteo drugs and received senior management buy-in to pursue a $12 MM growth opportunity for Caltrate

• Represented pharmaceutical Rx products in different therapeutic classes (HRT, Anti-depressents, OCs, Sleep aids) in a territory containing 80 Primary Care Physicians• Analyzed trends and data to target and achieve higher growth of sales revenue